HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
5th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 18-20 | Hybrid Event
Applied biotechnology
Applied biotechnology
(2-1). Bioremediation
(2-2). Biosurfactants
(2-3). Microbial factories
(2-4). Biotechnologically relevant enzymes
(2-5). Microbial physiology
(2-6). Future Bioindustries
(2-7). Physiological Engineering
(2-8). Penicillin Biosynthesis
(2-9). Morphology in Submerged Cultures
(2-10). Re-Streaking Techniques
Committee Members
Michele Mishto
Francis Crick Institute, United Kingdom
Thomas J Webster
Interstellar Therapeutics, United States
Murray Moo Young
University of Waterloo, Canada ECBB 2025 Speakers
Luis Jesus Villarreal Gomez
Universidad Autonoma de Baja California, Mexico
Assad Al Ammar
Specialty Enzymes and Probiotics, United States
Tina Moller Tagmose
Novo Nordisk A/S, Denmark
Yin Ying Ho
Agency for Science, Technology and Research (A*STAR), SingaporeSubmit your abstract Today
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico